Relations between neurometabolism and clinical biomarkers in patients with metabolic disease
The global prevalence of metabolic diseases, including hypertension, type 2 diabetes mellitus (T2DM), gout, and obesity, has significantly increased over the past two decades. The brain plays a central role in regulating both human behavior and metabolism. Understanding the potential connections amo...
Saved in:
| Main Authors: | Chao-Chao Chen, Ming-Shi Tan, Jiang-Tao Yin, Jian-Ming Li, Ying Li |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-04-01
|
| Series: | Frontiers in Neuroscience |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fnins.2025.1547010/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Neurometabolic therapy in chronic cerebral ischemia
by: E. Yu. Solovyeva, et al.
Published: (2025-03-01) -
Identification of retinol dehydrogenase 10 as a shared biomarker for metabolic dysfunction-associated steatotic liver disease and type 2 diabetes mellitus
by: Fangyu Li, et al.
Published: (2025-01-01) -
PET/CT Imaging of the Right Heart Perfusion and Glucose Metabolism Depending on a Risk Status in Patients With Idiopathic Pulmonary Arterial Hypertension
by: Natalia Goncharova, et al.
Published: (2025-01-01) -
Metabolic Syndrome. Particularities During SARS-CoV-2 Infection
by: Ana-Maria CIOTI, et al.
Published: (2021-06-01) -
Determining the Frequency of Metabolic Syndrome in Gout Patients in Rheumatology Clinics of Sari in 2023-24
by: Hengameh Babaee, et al.
Published: (2025-07-01)